Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2002 3
2003 4
2006 2
2007 1
2008 2
2009 4
2010 4
2011 1
2012 6
2013 4
2014 6
2015 4
2016 10
2017 8
2018 9
2019 4
2020 7
2021 3
2022 7
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
AR and PI3K Genomic Profiling of Cell-free DNA Can Identify Poor Responders to Lutetium-177-PSMA Among Patients with Metastatic Castration-resistant Prostate Cancer.
Vanwelkenhuyzen J, Van Bos E, Van Bruwaene S, Lesage K, Maes A, Üstmert S, Lavent F, Beels L, Grönberg H, Ost P, Lindberg J, De Laere B. Vanwelkenhuyzen J, et al. Among authors: maes a. Eur Urol Open Sci. 2023 May 30;53:63-66. doi: 10.1016/j.euros.2023.05.008. eCollection 2023 Jul. Eur Urol Open Sci. 2023. PMID: 37292496 Free PMC article.
225Ac-PSMA-617 radioligand therapy of de novo metastatic hormone-sensitive prostate carcinoma (mHSPC): preliminary clinical findings.
Sathekge M, Bruchertseifer F, Vorster M, Lawal IO, Mokoala K, Reed J, Maseremule L, Ndlovu H, Hlongwa K, Maes A, Morgenstern A, Van de Wiele C. Sathekge M, et al. Among authors: maes a. Eur J Nucl Med Mol Imaging. 2023 Jun;50(7):2210-2218. doi: 10.1007/s00259-023-06165-9. Epub 2023 Mar 3. Eur J Nucl Med Mol Imaging. 2023. PMID: 36864360 Free PMC article.
Dual time point imaging in locally advanced head and neck cancer to assess residual nodal disease after chemoradiotherapy.
Soffers F, Helsen N, Van den Wyngaert T, Carp L, Hoekstra OS, Goethals L, Martens M, Deben K, Spaepen K, De Bree R, De Geeter F, Zwezerijnen GJC, Van Laer C, Maes A, Lenssen O, Stroobants S; ECLYPS Investigators. Soffers F, et al. Among authors: maes a. EJNMMI Res. 2022 Jun 13;12(1):34. doi: 10.1186/s13550-022-00905-y. EJNMMI Res. 2022. PMID: 35695940 Free PMC article.
A Prospective Investigation of Tumor Hypoxia Imaging with 68Ga-Nitroimidazole PET/CT in Patients with Carcinoma of the Cervix Uteri and Comparison with 18F-FDG PET/CT: Correlation with Immunohistochemistry.
Mokoala KMG, Lawal IO, Maserumule LC, Hlongwa KN, Ndlovu H, Reed J, Bida M, Maes A, van de Wiele C, Mahapane J, Davis C, Jeong JM, Popoola G, Vorster M, Sathekge MM. Mokoala KMG, et al. Among authors: maes a. J Clin Med. 2022 Feb 12;11(4):962. doi: 10.3390/jcm11040962. J Clin Med. 2022. PMID: 35207237 Free PMC article.
mCRPC Patients Receiving 225Ac-PSMA-617 Therapy in the Post-Androgen Deprivation Therapy Setting: Response to Treatment and Survival Analysis.
Sathekge M, Bruchertseifer F, Vorster M, Lawal IO, Knoesen O, Mahapane J, Davis C, Mdlophane A, Maes A, Mokoala K, Mathabe K, Van C, Wiele D, Morgenstern A. Sathekge M, et al. Among authors: maes a. J Nucl Med. 2022 Oct;63(10):1496-1502. doi: 10.2967/jnumed.121.263618. Epub 2022 Feb 17. J Nucl Med. 2022. PMID: 35177427 Free PMC article.
75 results